Dianthus Therapeutics Correlations

DNTH Stock

19.42 0.07 0.36%

The current 90-days correlation between Dianthus Therapeutics and Park Electrochemical is 0.04 (i.e., Significant diversification). The correlation of Dianthus Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Dianthus Therapeutics Correlation With Market

Modest diversification

The correlation between Dianthus Therapeutics and DJI is 0.28 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Dianthus Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dianthus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more detail on how to invest in Dianthus Stock please use our How to Invest in Dianthus Therapeutics guide.

Moving together with Dianthus Stock

0.62

ELVN

Enliven Therapeutics

Pair Corr

Moving against Dianthus Stock

0.44	CVX	Chevron Corp	Pair Corr
0.39	XOM	Exxon Mobil Corp Earnings Call Next Week	Pair Corr
0.37	MMM	3M Company	Pair Corr

Related Correlations Analysis

	CF	PKE	AXTA	ALTO	KWR	AVNT	ALB-PA	HWKN
CF		0.73	0.29	0.55	0.12	0.17	0.73	0.48	CF
PKE	0.73		0.53	0.37	0.5	0.46	0.66	0.7	PKE
AXTA	0.29	0.53		0.25	0.62	0.81	0.16	0.09	AXTA
ALTO	0.55	0.37	0.25		0.28	0.15	0.46	0.22	ALTO
KWR	0.12	0.5	0.62	0.28		0.85	0.35	0.44	KWR
AVNT	0.17	0.46	0.81	0.15	0.85		0.33	0.22	AVNT
ALB-PA	0.73	0.66	0.16	0.46	0.35	0.33		0.68	ALB-PA
HWKN	0.48	0.7	0.09	0.22	0.44	0.22	0.68		HWKN
	CF	PKE	AXTA	ALTO	KWR	AVNT	ALB-PA	HWKN

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Dianthus Stock performing well and Dianthus Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Dianthus Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Treynor Ratio	Potential Upside	Value @Risk	Maximum Drawdown
CF	1.67	(0.15)	(0.27)	2.51	(4.59)	15.08
PKE	1.33	(0.04)	(0.12)	2.27	(2.98)	7.97
AXTA	1.40	(0.09)	(0.14)	2.13	(3.07)	12.04
ALTO	3.48	0.05	(0.02)	9.70	(6.00)	19.74
KWR	1.57	(0.17)	(0.26)	2.99	(4.00)	8.76
AVNT	1.49	(0.23)	(0.27)	2.89	(2.77)	8.24
ALB-PA	1.67	(0.18)	(0.30)	3.60	(3.59)	11.25
HWKN	1.99	(0.21)	(0.26)	3.42	(4.05)	12.24

Dianthus Therapeutics Corporate Management

Jennifer Ruff	VP Affairs	Profile
Edward Carr	Chief Officer	Profile
Kristina Maximenko	Chief Officer	Profile
MD MBA	Chief Officer	Profile
Adam Esq	General Counsel	Profile
Judson Taylor	Senior Operations	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC